Thai health authorities have raised concerns about a possible increase in Covid-19 cases following the Songkran festival, ...

Researchers at the University of Pennsylvania, in collaboration with experts in Finland, have developed an experimental ...

In other H5N1 developments, the WHO releases surveillance guidance for human cases, and the USDA announces new funding to ...

Overall, 58% were prescribed antivirals during their UC or ED visit, with 67% of prescribing occurring on the encounter date. Among those prescribed antivirals, 3,050 (80%) had them dispensed, with 65 ...

Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans. Developed by researchers at the Walter ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The global antiviral drugs market is poised for steady expansion, projected to reach a valuation of USD 89.68 billion by 2033, up from USD 61.42 billion in 2023, growing at a Comp ...

Research from the Keck School of Medicine has found that COVID-19 therapies cause few serious side effects, based on an ...

A chewing gum made from lablab beans may be the next big tool in fighting viral transmission. Scientists found that this gum can neutralize influenza and herpes viruses by over 95% by targeting the ...

The Michigan Court of Appeals, in effect, ruled that Chelsea Hospital and the drugmaker, Gilead Sciences Inc., are immune ...

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.